tiprankstipranks
Trending News
More News >
CARE Ratings Ltd (IN:CARERATING)
:CARERATING
India Market
Advertisement

CARE Ratings Ltd (CARERATING) AI Stock Analysis

Compare
4 Followers

Top Page

IN:CARERATING

CARE Ratings Ltd

(CARERATING)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
₹1,766.00
▲(12.18% Upside)
CARE Ratings Ltd demonstrates strong financial performance with robust profitability and a stable balance sheet, which are the most significant factors contributing to the score. Technical analysis indicates short-term bullish momentum, although the valuation suggests the stock is fairly priced. The absence of earnings call data and corporate events does not impact the score.

CARE Ratings Ltd (CARERATING) vs. iShares MSCI India ETF (INDA)

CARE Ratings Ltd Business Overview & Revenue Model

Company DescriptionCARE Ratings Ltd (CARERATING) is a leading credit rating agency in India, providing a wide range of rating services across various sectors, including corporate, financial institutions, public finance, and structured finance. The company offers credit ratings, research, and risk assessment services, enabling stakeholders to make informed financial decisions. With a strong focus on enhancing the transparency and credibility of financial markets, CARERATING plays a pivotal role in assessing the creditworthiness of issuers and their debt instruments.
How the Company Makes MoneyCARE Ratings generates revenue primarily through its credit rating services, which include fees charged for conducting ratings, surveillance, and updates on rated entities. The company also earns income from research reports and advisory services offered to clients, which are essential for businesses seeking to understand market conditions and make strategic financial decisions. Additionally, CARERATING may have partnerships with financial institutions and government bodies that enhance its service offerings and client base, contributing to its overall earnings. The growth in corporate borrowing and the increasing need for transparent credit assessments in the evolving financial landscape further bolster the company's revenue streams.

CARE Ratings Ltd Financial Statement Overview

Summary
CARE Ratings Ltd exhibits strong financial health with robust profitability and a stable balance sheet. The company demonstrates efficient cash flow management, though opportunities for further cash flow improvements exist.
Income Statement
85
Very Positive
CARE Ratings Ltd has shown a strong revenue growth trajectory with a notable increase from 2024 to 2025, enhancing its gross profit and net profit margins. The company maintains impressive EBIT and EBITDA margins, indicating efficient cost management and robust profitability.
Balance Sheet
80
Positive
The balance sheet reflects financial stability, with a low debt-to-equity ratio and a strong equity position. The return on equity is commendable, showing effective use of equity to generate profits. A high equity ratio further demonstrates the company's solid financial foundation.
Cash Flow
75
Positive
CARE Ratings Ltd displays healthy cash flow management, with a significant increase in free cash flow. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although the free cash flow growth rate suggests potential for further improvement.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.17B4.02B3.32B2.79B2.47B2.39B
Gross Profit2.05B1.98B1.49B1.45B1.35B1.18B
EBITDA1.99B1.55B1.59B1.37B1.07B1.27B
Net Income1.42B1.37B1.01B835.29M751.08M895.16M
Balance Sheet
Total Assets0.009.58B8.42B7.70B7.27B6.72B
Cash, Cash Equivalents and Short-Term Investments6.41B6.47B6.23B5.65B5.22B4.94B
Total Debt0.00237.69M195.54M174.78M89.13M72.26M
Total Liabilities-8.16B1.42B1.17B905.77M745.98M787.34M
Stockholders Equity8.16B8.06B7.17B6.72B6.47B5.89B
Cash Flow
Free Cash Flow1.09B1.08B817.10M707.36M490.20M816.84M
Operating Cash Flow1.15B1.23B908.82M822.42M680.03M861.74M
Investing Cash Flow-1.08B-584.28M-390.66M128.80M-273.18M-377.19M
Financing Cash Flow-246.39M-539.96M-629.55M-633.31M-351.38M-433.64M

CARE Ratings Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1574.30
Price Trends
50DMA
1568.18
Positive
100DMA
1658.52
Negative
200DMA
1484.12
Positive
Market Momentum
MACD
12.68
Negative
RSI
58.54
Neutral
STOCH
72.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CARERATING, the sentiment is Positive. The current price of 1574.3 is above the 20-day moving average (MA) of 1565.88, above the 50-day MA of 1568.18, and above the 200-day MA of 1484.12, indicating a bullish trend. The MACD of 12.68 indicates Negative momentum. The RSI at 58.54 is Neutral, neither overbought nor oversold. The STOCH value of 72.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CARERATING.

CARE Ratings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹48.10B33.711.12%21.24%36.98%
72
Outperform
₹62.63B33.200.96%8.06%24.52%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
₹345.45B46.111.25%6.61%11.88%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CARERATING
CARE Ratings Ltd
1,612.95
159.97
11.01%
IN:CRISIL
CRISIL Limited
4,723.75
-750.02
-13.70%
IN:ICRA
ICRA Limited
6,274.45
-575.76
-8.40%

CARE Ratings Ltd Corporate Events

CARE Ratings Transfers Equity Shares to Investor Protection Fund
Sep 1, 2025

CARE Ratings Limited has announced the transfer of equity shares to the Investor Education and Protection Fund Authority, as required by the Companies Act, 2013. This move, communicated through newspaper advertisements and letters to shareholders, reflects the company’s compliance with regulatory obligations, potentially impacting shareholder dynamics and reinforcing its commitment to governance standards.

CARE Ratings Expands Share Capital with Employee Stock Option Allotment
Aug 5, 2025

CARE Ratings Limited has announced the allotment of 16,066 equity shares to its employees under the CARE Employee Stock Option Scheme 2020, following approval by the Nomination and Remuneration Committee. This allotment will increase the company’s paid-up share capital, reflecting its commitment to employee engagement and retention through stock-based incentives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025